Edesa Biotech Inc (EDSA)
4.58
-0.05
(-1.13%)
USD |
NASDAQ |
May 06, 16:00
4.58
0.00 (0.00%)
After-Hours: 20:00
Edesa Biotech Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2020 | -0.0018M |
| June 30, 2020 | 0.1085M |
| March 31, 2020 | 0.1005M |
| December 31, 2019 | 0.104M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | 0.018M |
| December 31, 2018 | -0.0532M |
| September 30, 2018 | -0.0351M |
| June 30, 2018 | -0.0421M |
| March 31, 2018 | -0.076M |
| December 31, 2017 | -0.0804M |
| September 30, 2017 | -0.0911M |
| June 30, 2017 | -0.1217M |
| March 31, 2017 | -0.0718M |
| December 31, 2016 | -0.0215M |
| September 30, 2016 | 0.0725M |
| June 30, 2016 | 0.002M |
| March 31, 2016 | -0.0218M |
| December 31, 2015 | 0.0912M |
| September 30, 2015 | 0.1329M |
| June 30, 2015 | -0.1277M |
| March 31, 2015 | -0.1224M |
| December 31, 2014 | 0.0356M |
| Date | Value |
|---|---|
| August 31, 2014 | -0.2871M |
| May 31, 2014 | -0.0328M |
| February 28, 2014 | -0.0058M |
| November 30, 2013 | -0.0625M |
| August 31, 2013 | 0.0572M |
| May 31, 2013 | -0.0288M |
| February 28, 2013 | -0.0395M |
| November 30, 2012 | -0.0477M |
| August 31, 2012 | -0.0145M |
| May 31, 2012 | -0.0531M |
| February 29, 2012 | -0.0866M |
| November 30, 2011 | -0.0957M |
| August 31, 2011 | -0.5269M |
| May 31, 2011 | -0.0874M |
| February 28, 2011 | 0.3761M |
| November 30, 2010 | -0.0849M |
| August 31, 2010 | 0.4489M |
| May 31, 2010 | 0.0495M |
| January 31, 2010 | 0.00 |
| October 31, 2009 | 0.00 |
| April 30, 2009 | 0.00 |
| January 31, 2009 | 0.00 |
| October 31, 2008 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.0018M
Minimum
Sep 2020
0.1085M
Maximum
Jun 2020
0.0778M
Average
0.1023M
Median
Gross Profit (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 39.70M |
| Lexaria Bioscience Corp | 0.145M |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |